Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  9,435 results for ""Benzyl Compounds""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

6-benzylaminopurine highly sensitive analysis by SPR sensor with bifunctional magnetic molecularly imprinted polymers nanoparticles.

  • Authors : Xiong Y; Hunan Provincial Key Laboratory of Food Science and Biotechnology, College of Food Science and Technology, Hunan Agricultural University, Changsha 410128, PR China.; Cao Y

Subjects: Benzyl Compounds*/Benzyl Compounds*/Benzyl Compounds*/chemistry ; Benzyl Compounds*/Benzyl Compounds*/Benzyl Compounds*/analysis ; Vegetables*/Vegetables*/Vegetables*/chemistry

  • Source: Food chemistry [Food Chem] 2024 Nov 01; Vol. 457, pp. 140083. Date of Electronic Publication: 2024 Jun 13.Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 7702639 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.

  • Authors : Keenan A; Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. .; Whichello C

Subjects: Patient Preference* ; Sphingosine 1 Phosphate Receptor Modulators*/Sphingosine 1 Phosphate Receptor Modulators*/Sphingosine 1 Phosphate Receptor Modulators*/therapeutic use ; Sphingosine 1 Phosphate Receptor Modulators*/Sphingosine 1 Phosphate Receptor Modulators*/Sphingosine 1 Phosphate Receptor Modulators*/pharmacology

  • Source: The patient [Patient] 2024 Nov; Vol. 17 (6), pp. 685-696. Date of Electronic Publication: 2024 May 15.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101309314 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series.

  • Authors : Bianco A; Department of Translational Biomedicines and Neurosciences, University of Bari Aldo Moro, Italy.; Guerra T

Subjects: Fingolimod Hydrochloride*/Fingolimod Hydrochloride*/Fingolimod Hydrochloride*/therapeutic use ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy ; Benzyl Compounds*/Benzyl Compounds*/Benzyl Compounds*/therapeutic use

  • Source: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2024 Oct; Vol. 245, pp. 108475. Date of Electronic Publication: 2024 Aug 06.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models.

  • Authors : Hendek HH; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany.; Blusch A

Subjects: Azetidines*/Azetidines*/Azetidines*/pharmacology ; Azetidines*/Azetidines*/Azetidines*/therapeutic use ; Benzyl Compounds*/Benzyl Compounds*/Benzyl Compounds*/pharmacology

  • Source: Scientific reports [Sci Rep] 2024 Aug 01; Vol. 14 (1), pp. 17823. Date of Electronic Publication: 2024 Aug 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment.

  • Authors : Hu S; Department of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Hu Y

Subjects: Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Osteoporosis*/Osteoporosis*/Osteoporosis*/metabolism ; Osteoclasts*/Osteoclasts*/Osteoclasts*/drug effects

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Jul 05; Vol. 974, pp. 176630. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications.

  • Authors : Spiezia AL; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Via Sergio Pansini 5, 80131, Naples, Italy.; Scalia G

Subjects: Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/immunology ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/blood

  • Source: Journal of neurology [J Neurol] 2024 Jul; Vol. 271 (7), pp. 4281-4291. Date of Electronic Publication: 2024 Apr 17.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.

  • Authors : Sanna K; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.; Bruno A

Subjects: Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/immunology ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy ; T-Lymphocytes*/T-Lymphocytes*/T-Lymphocytes*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 07; Vol. 15, pp. 1416133. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The Mechanism of Exogenous Salicylic Acid and 6-Benzylaminopurine Regulating the Elongation of Maize Mesocotyl.

  • Authors : Qi X; College of Agronomy, Gansu Agricultural University, Lanzhou 730070, China.; Gansu Provincial Key Laboratory of Aridland Crop Science, Gansu Agricultural University, Lanzhou 730070, China.

Subjects: Zea mays*/Zea mays*/Zea mays*/growth & development ; Zea mays*/Zea mays*/Zea mays*/drug effects ; Zea mays*/Zea mays*/Zea mays*/genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 03; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Extracellular acidification attenuates bronchial contraction via an autocrine activation of EP 2 receptor: Its diminishment in murine experimental asthma.

  • Authors : Chiba Y; Laboratory of Molecular Biology and Physiology, Japan. Electronic address: .; Yamane Y

Subjects: Acetylcholine*/Acetylcholine*/Acetylcholine*/pharmacology ; Asthma* ; Benzyl Compounds*

  • Source: Respiratory physiology & neurobiology [Respir Physiol Neurobiol] 2024 Jun; Vol. 324, pp. 104251. Date of Electronic Publication: 2024 Mar 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101140022 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series.

  • Authors : Chang EH; MS & Neuroimmunology Clinics, Concord Repatriation General Hospital, University of Sydney, NSW, Sydney, Australia. Electronic address: .; Hardy TA

Subjects: Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/complications ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/chemically induced

  • Source: Journal of neuroimmunology [J Neuroimmunol] 2024 Apr 15; Vol. 389, pp. 578330. Date of Electronic Publication: 2024 Mar 14.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 8109498 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  9,435 results for ""Benzyl Compounds""